Charles J. Fisher's most recent trade in Aethlon Medical Inc was a trade of 192,600 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 10, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aethlon Medical Inc | Charles J. Fisher | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 192,600 | 192,600 | - | - | Employee Stock Option (Right to Buy) | |
| Aethlon Medical Inc | Charles J. Fisher | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2021 | 266,888 | 266,888 | - | - | Employee Stock Option (Right to Buy) | |
| Aethlon Medical Inc | Charles J. Fisher | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.03 per share. | 31 Mar 2021 | 2,575 | 19,569 (0%) | 0% | 2.0 | 5,227 | Common Stock |
| Aethlon Medical Inc | Charles J. Fisher | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2020 | 239,122 | 239,122 | - | - | Employee Stock Option (Right to Buy) | |
| Aethlon Medical Inc | Charles J. Fisher | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.35 per share. | 30 Sep 2020 | 2,389 | 24,719 (0%) | 0% | 1.3 | 3,225 | Common Stock |